153 related articles for article (PubMed ID: 30286326)
1. Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.
Williams AP; Garner EF; Waters AM; Stafman LL; Aye JM; Markert H; Stewart JE; Beierle EA
Transl Oncol; 2019 Jan; 12(1):84-95. PubMed ID: 30286326
[TBL] [Abstract][Full Text] [Related]
2. Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma.
Bownes LV; Marayati R; Quinn CH; Beierle AM; Hutchins SC; Julson JR; Erwin MH; Stewart JE; Mroczek-Musulman E; Ohlmeyer M; Aye JM; Yoon KJ; Beierle EA
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454859
[TBL] [Abstract][Full Text] [Related]
3. FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.
Garner EF; Williams AP; Stafman LL; Aye JM; Mroczek-Musulman E; Moore BP; Stewart JE; Friedman GK; Beierle EA
Sci Rep; 2018 May; 8(1):6913. PubMed ID: 29720672
[TBL] [Abstract][Full Text] [Related]
4. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
[TBL] [Abstract][Full Text] [Related]
5. EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.
Bownes LV; Williams AP; Marayati R; Stafman LL; Markert H; Quinn CH; Wadhwani N; Aye JM; Stewart JE; Yoon KJ; Mroczek-Musulman E; Beierle EA
PLoS One; 2021; 16(3):e0246244. PubMed ID: 33690617
[TBL] [Abstract][Full Text] [Related]
6. PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.
Stafman LL; Williams AP; Marayati R; Aye JM; Stewart JE; Mroczek-Musulman E; Beierle EA
PLoS One; 2019; 14(4):e0214469. PubMed ID: 30969990
[TBL] [Abstract][Full Text] [Related]
7. Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells.
Kim MO; Choe MH; Yoon YN; Ahn J; Yoo M; Jung KY; An S; Hwang SG; Oh JS; Kim JS
Biochem Pharmacol; 2017 Nov; 144():78-89. PubMed ID: 28813646
[TBL] [Abstract][Full Text] [Related]
8. PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects.
Rincón R; Cristóbal I; Zazo S; Arpí O; Menéndez S; Manso R; Lluch A; Eroles P; Rovira A; Albanell J; García-Foncillas J; Madoz-Gúrpide J; Rojo F
Oncotarget; 2015 Feb; 6(6):4299-314. PubMed ID: 25726524
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer.
Cristóbal I; González-Alonso P; Daoud L; Solano E; Torrejón B; Manso R; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Mar Drugs; 2015 May; 13(6):3276-86. PubMed ID: 26023836
[TBL] [Abstract][Full Text] [Related]
10. Regulation of PP2A by Sphingolipid Metabolism and Signaling.
Oaks J; Ogretmen B
Front Oncol; 2014; 4():388. PubMed ID: 25642418
[TBL] [Abstract][Full Text] [Related]
11. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.
Chen KF; Liu CY; Lin YC; Yu HC; Liu TH; Hou DR; Chen PJ; Cheng AL
Oncogene; 2010 Nov; 29(47):6257-66. PubMed ID: 20729919
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells.
Liu L; Huang Z; Chen J; Wang J; Wang S
J Exp Clin Cancer Res; 2018 Jul; 37(1):142. PubMed ID: 29986744
[TBL] [Abstract][Full Text] [Related]
13. The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors.
Cucinotta L; Filippone A; Casili G; Lanza M; Bova V; Capra AP; Giuffrida R; Colarossi C; Sciacca D; Paterniti I; Cuzzocrea S; Campolo M; Esposito E
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555359
[TBL] [Abstract][Full Text] [Related]
14. Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.
Huang Q; Qin S; Yuan X; Zhang L; Ji J; Liu X; Ma W; Zhang Y; Liu P; Sun Z; Zhang J; Liu Y
Oncol Rep; 2017 Jul; 38(1):598-606. PubMed ID: 28560452
[TBL] [Abstract][Full Text] [Related]
15. Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target.
Khanna A; Pimanda JE; Westermarck J
Cancer Res; 2013 Nov; 73(22):6548-53. PubMed ID: 24204027
[TBL] [Abstract][Full Text] [Related]
16. Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2A.
Jin L; Si Y; Hong X; Liu P; Zhu B; Yu H; Zhao X; Qin S; Xiong M; Liu Y; Luo Z; Guo Y
Int J Oncol; 2018 May; 52(5):1569-1578. PubMed ID: 29568959
[TBL] [Abstract][Full Text] [Related]
17. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.
Cristóbal I; Garcia-Orti L; Cirauqui C; Alonso MM; Calasanz MJ; Odero MD
Leukemia; 2011 Apr; 25(4):606-14. PubMed ID: 21233840
[TBL] [Abstract][Full Text] [Related]
18. Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer.
Kauko O; Westermarck J
Int J Biochem Cell Biol; 2018 Mar; 96():157-164. PubMed ID: 29355757
[TBL] [Abstract][Full Text] [Related]
19. Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors.
Smith AM; Dun MD; Lee EM; Harrison C; Kahl R; Flanagan H; Panicker N; Mashkani B; Don AS; Morris J; Toop H; Lock RB; Powell JA; Thomas D; Guthridge MA; Moore A; Ashman LK; Skelding KA; Enjeti A; Verrills NM
Oncotarget; 2016 Jul; 7(30):47465-47478. PubMed ID: 27329844
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
